Measurement characteristics of two asthma symptom diary scales for use in clinical trials

The measurement characteristics of two asthma symptom diary scales developed for use as health outcome measures in clinical trials of asthma therapy were investigated. A daytime diary scale was designed to capture the frequency and inconvenience of daytime asthma symptoms and their effects on activities, and a nocturnal asthma symptom diary scale was designed to capture awakenings with asthma symptoms. The internal consistency, reliability, validity and responsiveness of both asthma diary scales were assessed in 346 adult asthma patients in two placebo-controlled clinical trials of an investigational asthma therapy, a leukotriene biosynthesis inhibitor. The daytime symptom scale showed sufficient internal consistency (0.90-0.92), and the daytime and nocturnal symptom scales showed sufficient test retest reliability (0.69-0.87). Construct validity was demonstrated by generally moderate-to-strong correlations for changes in the diary scales with changes in other measures of asthma status, such as forced expiratory volume in one second (FEV1), peak expiratory flow (PEF), and puffs of beta-agonist inhaler. Both scales demonstrated significant responsiveness to change in asthma due to therapy in one of the clinical trials. Based on these results, the daytime and nocturnal asthma symptom diary scales show measurement characteristics appropriate for use as asthma outcome measures in clinical trials of asthma therapy.

This article has been cited by other articles:

				H. K. Reddel, D. R. Taylor, E. D. Bateman, L.-P. Boulet, H. A. Boushey, W. W. Busse, T. B. Casale, P. Chanez, P. L. Enright, P. G. Gibson, et al. An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations: Standardizing Endpoints for Clinical Asthma Trials and Clinical Practice Am. J. Respir. Crit. Care Med., July 1, 2009; 180(1): 59 - 99. [Abstract] [Full Text] [PDF]

				E J Hothersall, R Chaudhuri, C McSharry, I Donnelly, J Lafferty, A D McMahon, C J Weir, J Meiklejohn, N Sattar, I McInnes, et al. Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma Thorax, December 1, 2008; 63(12): 1070 - 1075. [Abstract] [Full Text] [PDF]

				W. W. Busse, E. Israel, H. S. Nelson, J. W. Baker, B. L. Charous, D. Y. Young, V. Vexler, R. S. Shames, and the Daclizumab Asthma Study Group Daclizumab Improves Asthma Control in Patients with Moderate to Severe Persistent Asthma: A Randomized, Controlled Trial Am. J. Respir. Crit. Care Med., November 15, 2008; 178(10): 1002 - 1008. [Abstract] [Full Text] [PDF]

				E. Livingston, R. Chaudhuri, A. D. McMahon, I. Fraser, C. P. McSharry, and N. C. Thomson Systemic sensitivity to corticosteroids in smokers with asthma Eur. Respir. J., January 1, 2007; 29(1): 64 - 71. [Abstract] [Full Text] [PDF]

				R. Chaudhuri, E. Livingston, A. D. McMahon, J. Lafferty, I. Fraser, M. Spears, C. P. McSharry, and N. C. Thomson Effects of Smoking Cessation on Lung Function and Airway Inflammation in Smokers with Asthma Am. J. Respir. Crit. Care Med., July 15, 2006; 174(2): 127 - 133. [Abstract] [Full Text] [PDF]

				S. L. Johnston, F. Blasi, P. N. Black, R. J. Martin, D. J. Farrell, R. B. Nieman, and the TELICAST Investigators The Effect of Telithromycin in Acute Exacerbations of Asthma N. Engl. J. Med., April 13, 2006; 354(15): 1589 - 1600. [Abstract] [Full Text] [PDF]

				D. Peters, C. Chen, L. E. Markson, F. C. Allen-Ramey, and W. M. Vollmer Using an asthma control questionnaire and administrative data to predict health-care utilization. Chest, April 1, 2006; 129(4): 918 - 924. [Abstract] [Full Text] [PDF]

				E.F. Juniper, M.E. Wisniewski, F.M. Cox, A.H. Emmett, K.E. Nielsen, and P.M. O'Byrne Relationship between quality of life and clinical status in asthma: a factor analysis Eur. Respir. J., February 1, 2004; 23(2): 287 - 291. [Abstract] [Full Text] [PDF]

				R. Chaudhuri, E. Livingston, A. D. McMahon, L. Thomson, W. Borland, and N. C. Thomson Cigarette Smoking Impairs the Therapeutic Response to Oral Corticosteroids in Chronic Asthma Am. J. Respir. Crit. Care Med., December 1, 2003; 168(11): 1308 - 1311. [Abstract] [Full Text] [PDF]

				M J Vaquerizo, P Casan, J Castillo, M Perpina, J Sanchis, V Sobradillo, A Valencia, H Verea, J L Viejo, C Villasante, et al. Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma Thorax, March 1, 2003; 58(3): 204 - 210. [Abstract] [Full Text] [PDF]

				D B Price, D Hernandez, P Magyar, J Fiterman, K M Beeh, I G James, S Konstantopoulos, R Rojas, J A van Noord, M Pons, et al. Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma Thorax, March 1, 2003; 58(3): 211 - 216. [Abstract] [Full Text] [PDF]

				R.A. Baumgartner, G. Martinez, J.M. Edelman, G.G. Rodriguez Gomez, M. Bernstein, S. Bird, R. Angner, A. Polis, S.B. Dass, S. Lu, et al. Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone Eur. Respir. J., January 1, 2003; 21(1): 123 - 128. [Abstract] [Full Text] [PDF]

				J. Zhang, C. Yu, S.T. Holgate, and T.F. Reiss Variability and lack of predictive ability of asthma end-points in clinical trials Eur. Respir. J., November 1, 2002; 20(5): 1102 - 1109. [Abstract] [Full Text] [PDF]

				A B Chang, V A Harrhy, J Simpson, I B Masters, and P G Gibson Cough, airway inflammation, and mild asthma exacerbation Arch. Dis. Child., April 1, 2002; 86(4): 270 - 275. [Abstract] [Full Text] [PDF]

				W. M. VOLLMER, L. E. MARKSON, E. O'CONNOR, E. ANN FRAZIER, M. BERGER, and A. S. BUIST Association of Asthma Control with Health Care Utilization . A Prospective Evaluation Am. J. Respir. Crit. Care Med., January 15, 2002; 165(2): 195 - 199. [Abstract] [Full Text] [PDF]

				S.-E. DAHLEN, K. MALMSTROM, E. NIZANKOWSKA, B. DAHLEN, P. KUNA, M. KOWALSKI, W. R. LUMRY, C. PICADO, D. D. STEVENSON, J. BOUSQUET, et al. Improvement of Aspirin-Intolerant Asthma by Montelukast, a Leukotriene Antagonist . A Randomized, Double-Blind, Placebo-Controlled Trial Am. J. Respir. Crit. Care Med., January 1, 2002; 165(1): 9 - 14. [Abstract] [Full Text] [PDF]

				S. Shingo, J. Zhang, and T.F. Reiss Correlation of airway obstruction and patient-reported endpoints in clinical studies Eur. Respir. J., February 1, 2001; 17(2): 220 - 224. [Abstract] [Full Text] [PDF]

				A. Reicin, R. White, S. F. Weinstein, A. F. Finn Jr, H. Nguyen, I. Peszek, L. Geissler, B. C. Seidenberg, and for the Montelukast/Loratadine Study Group Montelukast, a Leukotriene Receptor Antagonist, in Combination With Loratadine, a Histamine Receptor Antagonist, in the Treatment of Chronic Asthma Arch Intern Med, September 11, 2000; 160(16): 2481 - 2488. [Abstract] [Full Text]

				A. G. Mainous III, W. J. Hueston, and M. K. Connor Serum Vitamin C Levels and Use of Health Care Resources for Wheezing Episodes Arch Fam Med, March 1, 2000; 9(3): 241 - 245. [Abstract] [Full Text] [PDF]

				M. LAVIOLETTE, K. MALMSTROM, S. LU, P. CHERVINSKY, J.-C. PUJET, I. PESZEK, J. ZHANG, and T. F. REISS Montelukast Added to Inhaled Beclomethasone in Treatment of Asthma Am. J. Respir. Crit. Care Med., December 1, 1999; 160(6): 1862 - 1868. [Abstract] [Full Text]

				C.-G. Löfdahl, T. F Reiss, J. A Leff, E. Israel, M. J Noonan, A. F Finn, B. C Seidenberg, T. Capizzi, S. Kundu, and P. Godard Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients BMJ, July 10, 1999; 319(7202): 87 - 90. [Abstract] [Full Text]

				N. C Santanello, G. Davies, S. P Galant, A. Pedinoff, R. Sveum, J. Seltzer, B. C Seidenberg, and B. A Knorr Validation of an asthma symptom diary for interventional studies Arch. Dis. Child., May 1, 1999; 80(5): 414 - 420. [Abstract] [Full Text]

				K. Malmstrom, G. Rodriguez-Gomez, J. Guerra, C. Villaran, A. Pineiro, L. X. Wei, B. C. Seidenberg, T. F. Reiss, and for the Montelukast/Beclomethasone Study Group* Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic Asthma: A Randomized, Controlled Trial Ann Intern Med, March 16, 1999; 130(6): 487 - 495. [Abstract] [Full Text] [PDF]

				T. F. Reiss, P. Chervinsky, R. J. Dockhorn, S. Shingo, B. Seidenberg, T. B. Edwards, and for the Montelukast Clinical Research Study Group Montelukast, a Once-Daily Leukotriene Receptor Antagonist, in the Treatment of Chronic Asthma: A Multicenter, Randomized, Double-blind Trial Arch Intern Med, June 8, 1998; 158(11): 1213 - 1220. [Abstract] [Full Text] [PDF]